Accelerating Drug Discovery with Synthetic Biology
eBook: Accelerating Drug Discovery with Synthetic Biology
Although technological and automation advancements have helped accelerate antibody discovery, the development of complex antibody-based drugs and therapeutics remains challenging. Synthetic biology has recently emerged as a way to break free of traditional bottlenecks and improve antibody discovery workflows.
This eBook explains how synthetic biology can be used to connect high-content sequencing data from B cell discovery platforms to downstream high-throughput antibody screening and characterization workflows to maintain consistent and high-throughput processes throughout discovery operations.
Topics covered in this eBook also include:
- Use of synthetic biology workflows to complete antibody cloning in days not weeks
- How to produce transfection-ready plasmids in a fraction of the time previously required
- Steps to take to accelerate lead identification
- The advantages of building scFv constructs using synthetic biology
Complete the adjacent form today for access to the eBook.
"*" indicates required fields
By clicking submit, you agree that Telesis Bio may use this information to contact you about our programs, products, or services. You may opt out at any time.